Clinical trial
Safety and Immunogenicity of Fluzone Influenza Virus Vaccine (2005-2006 Formulation) Among Healthy Children 6 to 12 Weeks of Age
NCT00242424 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity of Fluzone Influenza Virus Vaccine (2005-2006 Formulation) Among Healthy Children 6 to 12 Weeks of Age
- Lead sponsor
- Seattle Children's Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- September 30, 2007
- Enrollment
- 1,375 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inactivated influenza vaccine